Literature DB >> 17184873

Factors influencing participation in cutaneous screening among individuals with a family history of melanoma.

Lora M Azzarello1, Paul B Jacobsen.   

Abstract

BACKGROUND: Targeting higher risk individuals, such as melanoma patients' first-degree relatives, may be more efficient than mass skin cancer screening.
OBJECTIVE: Our aim was to examine prevalence and predictors of total cutaneous examination in first-degree relatives.
METHODS: Ninety-five first-degree relatives completed questionnaires assessing demographic and risk characteristics, perceived risk, perceived severity, self-efficacy, response efficacy, and total skin examination. Fourteen months later, first-degree relatives were asked if they had obtained a total skin examination during follow-up.
RESULTS: At baseline, 47% reported at least one total cutaneous examination and 27% had a health care provider recommendation for total skin examination. At follow-up, 37% had obtained a total skin examination. Baseline and follow-up total cutaneous examination was associated with more risk factors, higher education, provider recommendation, and greater perceived risk and severity. In multivariate analyses, provider recommendation and college education predicted follow-up total skin examination. LIMITATIONS: Data were self reported. Knowledge, health-care access, and follow-up provider recommendation were not assessed.
CONCLUSION: Physicians and other providers may be influential in promoting total cutaneous examination in first-degree relatives.

Entities:  

Mesh:

Year:  2006        PMID: 17184873     DOI: 10.1016/j.jaad.2006.10.024

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

1.  Brief questions highlight the need for melanoma information campaigns.

Authors:  Janet A Foote; Catherine M Poole
Journal:  J Cancer Educ       Date:  2013-12       Impact factor: 2.037

2.  Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics.

Authors:  Elliot J Coups; Sharon L Manne; Pamela Ohman Strickland; Michelle Hilgart; James S Goydos; Carolyn J Heckman; Paola Chamorro; Babar K Rao; Moira Davis; Franz O Smith; Frances P Thorndike; Lee M Ritterband
Journal:  Contemp Clin Trials       Date:  2019-06-27       Impact factor: 2.226

3.  Moderators of the Effects of mySmartSkin, a Web-Based Intervention to Promote Skin Self-examination and Sun Protection Among Individuals Diagnosed With Melanoma.

Authors:  Sharon Manne; Carolyn J Heckman; Deborah Kashy; Lee Ritterband; Frances Thorndike; Carolina Lozada; Elliot J Coups
Journal:  Ann Behav Med       Date:  2022-08-02

4.  Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection among individuals diagnosed with melanoma.

Authors:  Sharon L Manne; Carolyn J Heckman; Deborah A Kashy; Lee M Ritterband; Frances P Thorndike; Carolina Lozada; Elliot J Coups
Journal:  Transl Behav Med       Date:  2021-07-29       Impact factor: 3.046

5.  Correlates of sun protection behaviors among melanoma survivors.

Authors:  Carolyn J Heckman; Sharon L Manne; Deborah A Kashy; Trishnee Bhurosy; Lee Ritterband; Elliot J Coups
Journal:  BMC Public Health       Date:  2021-05-08       Impact factor: 3.295

6.  Do Subjective Norms Predict the Screening of Cancer Patients' First-Degree Relatives? A Systematic Review and Meta-Analysis.

Authors:  Mojtaba Fattahi Ardakani; Amin Salehi-Abargouei; Ahmad Sotoudeh; Somayyeh Esmaeildokht; Vali Bahrevar
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

7.  Anxiety, locus of control and sociodemographic factors associated with adherence to an annual clinical skin monitoring: a cross-sectional survey among 1000 high-risk French patients involved in a pilot-targeted screening programme for melanoma.

Authors:  Cédric Rat; Sandrine Hild; Aurelie Gaultier; Amir Khammari; Angelique Bonnaud-Antignac; Gaelle Quereux; Brigitte Dreno; Jean Michel Nguyen
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.